Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2026-02-21 @ 9:25 PM
Study NCT ID:
NCT00040092
Status:
COMPLETED
Last Update Posted:
2008-01-07
First Post:
2002-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer
Sponsor:
Aptose Biosciences Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LOR/VIR/P03/002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None